A sale of the medical distribution business could increase Henry Schein's (HSIC) shares by 20%, while EPS could jump by ~35% ...
Activist Ananym Capital Management is urging Henry Schein (HSIC) to refresh its board, cut costs, tackle succession planning and consider selling its medical distribution business, Svea Herbst-Bayliss ...
Activist investor Ananym Capital Management is urging healthcare products distributor Henry Schein to refresh its board, cut costs, tackle succession planning and consider selling its medical ...